| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $328 | +320.5% | +429.0% |
| R&D Expense | $11K | +120.0% | -97.0% |
| SG&A Expense | $230K | -4.2% | +46.2% |
| Operating Income | -$1.3M | +9.0% | -3.4% |
| Interest Expense | $52 | — | — |
| Net Income | -$1.2M | +1.3% | +5.5% |
| EPS (Basic) | -$0.28 |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $458K | +12.2% | -27.6% |
| Short-term Investments | $4.3M | -18.1% | +10.9% |
| Accounts Receivable | $224 | +1.8% | +14.3% |
| Current Assets | $5.1M | -12.2% | +6.8% |
| Total Assets | $6.8M | -9.2% | +40.4% |
| Current Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$3.5M | — | — |
| Capital Expenditures | $4K | — | — |
| Investing Cash Flow | -$1.6M | — | — |
| Financing Cash Flow | $4.4M | — | — |
| Free Cash Flow | -$3.5M | — | — |
| +33.3% |
| EPS (Diluted) | -$0.28 | +3.4% | +33.3% |
| $888K |
| +37.8% |
| +67.2% |
| Total Liabilities | $1.1M | +27.4% | +101.3% |
| Stockholders' Equity | $8.3M | -9.5% | +17.7% |